Lixia Jiao

6PUBLICATIONS
28CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Behavioural epidemiologyComputational statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 22, 2024
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.

Neila Sayah, Deepak L Bhatt, Michael Miller

|Feb 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.

Brian Olshansky, Deepak L Bhatt, Michael Miller

|Aug 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking.

Michael Miller, Deepak L Bhatt, Ph Gabriel Steg

|Apr 04, 2022
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.

Senthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg

|Mar 09, 2022
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg

|Oct 03, 2020
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results.

Brian Olshansky, Deepak L Bhatt, Michael Miller

Pageof 1